Literature DB >> 7206379

Selective abolition of Ca-dependent responses of smooth and cardiac muscles by flunarizine.

K Nakayama, Y Kasuya.   

Abstract

The inhibitory effect of flunarizine on the Ca-dependent responses was compared with that of verapamil in isolated smooth and cardiac muscles. Flunarizine at a small dose shifted to the right the dose-response curve for Ca2+ of the phasic contraction due to electric stimuli in rabbit basilar strips, while in a large dose, flunarizine reduced the maximum tension and slope of the dose-response curve. The high K+-induced vasoconstriction of the rabbit basilar artery was inhibited by flunarizine. However, the action of flunarizine was about 30 times slower than findings with verapamil. The spontaneous activity of the rat portal vein was less susceptible to flunarizine, whereas that of rat uterus was completely inhibited by flunarizine. Flunarizine possessed moderate negative chronotropic and inotropic actions on the right atria and papillary muscles of the rabbit. Our experiments indicate that flunarizine is selective in antagonizing Ca-dependent contraction of the rabbit basilar artery, probably by blockade of the transmembrane Ca. It is also possible that the slow onset of action and nonsurmountable antagonism produced by flunarizine is due to other pharmacological interventions such as delayed effect of metabolites, stabilizing action or tight binding on the cell membrane of vascular smooth muscles.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7206379     DOI: 10.1254/jjp.30.731

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  6 in total

1.  Local cerebral glucose utilization and local cerebral blood flow in conscious rats after administration of flunarizine.

Authors:  T Beck; J Krieglstein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-06       Impact factor: 3.000

2.  Assessment of "Ca2+ -antagonist" effects of drugs in K+ -depolarized smooth muscle. Differentiation of antagonist subgroups.

Authors:  M Spedding
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-02       Impact factor: 3.000

Review 3.  Flunarizine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use.

Authors:  B Holmes; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-01       Impact factor: 9.546

4.  Termination of a tachyarrhythmia by flunarizine is not a specific marker for a triggered mechanism.

Authors:  Sergey A Vitebskiy; Celeen M Khrestian; Albert L Waldo
Journal:  Heart Rhythm       Date:  2007-08-24       Impact factor: 6.343

5.  Effects of flunarizine on electrical and mechanical responses of smooth muscle cells in basilar and ear arteries of the rabbit.

Authors:  T Nagao; H Suzuki; H Kuriyama
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-08       Impact factor: 3.000

6.  Cinnarizine and flunarizine as radiation sensitisers in two murine tumours.

Authors:  P J Wood; D G Hirst
Journal:  Br J Cancer       Date:  1988-12       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.